Multicenter Follow Up Study Of Subjects Who Participated In An Original Protocol Of Exemestane Vs. Megestrol Acetate In Postmenopausal Women With Metastatic Breast Cancer
Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Pfizer
Age
Any age
Sex
FEMALE
Healthy volunteers
Not accepted
You may be eligible if
Previous participation in study 971-ONC-0028-080.
You may not be if
Subjects who had not previously participated in study 971-ONC-0028-080.
Clareo Health | Multicenter Follow Up Study Of Subjects Who Participated In An Original Protocol Of Exemestane Vs. Megestrol Acetate In Postmenopausal Women With Metastatic Breast Cancer
